Last reviewed · How we verify

NCT03458351

RIPC and Platelet Activation on Platelet Activation During Cardiopulmonary Bypass

Completed NA Last updated 15 October 2019
What this trial tests

NA trial testing Remote ischemic preconditioning in Platelet Dysfunction in 58 participants. Completed in 14 August 2019.

Timeline
28 March 2018
Primary endpoint
5 August 2019
14 August 2019

Quick facts

Lead sponsorSeoul National University Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposeprevention
Enrollment58
Start date28 March 2018
Primary completion5 August 2019
Estimated completion14 August 2019
Sites1 location across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

Seoul National University Hospital

Who can join

18 and older, any sex, with Platelet Dysfunction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this study, the investigators are going to investigate the effects of remote ischemic preconditioning on platelet activation in patients undergoing cardiac surgery with cardiopulmonary bypass.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Remote ischemic preconditioning

Trials testing the same drug.

Other recruiting trials for Platelet Dysfunction

Currently open trials in the same condition.

Other Seoul National University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03458351.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing